Lista de obras - Juliana Cassataro - Dominio Público Uruguay

A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses

article

A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response

artículo científico publicado en 2005

A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination

article by Juliana Cassataro et al published August 2007 in Vaccine

A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice

artículo científico publicado en 2002

A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses

artículo científico publicado en 2015

A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice

artículo científico publicado en 2006

A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination

article by Juliana Cassataro et al published May 2007 in Vaccine

An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice

artículo científico publicado en 2011

Antibodies to the CP24 protein of Brucella melitensis lack diagnostic usefulness in ovine brucellosis

scientific article published on 01 May 2003

Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae

artículo científico publicado en 2004

Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge

artículo científico publicado en 2015

Brucella abortus activates human neutrophils

artículo científico publicado en 2009

Brucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases

artículo científico publicado en 2013

Brucella abortus induces apoptosis of human T lymphocytes

Brucella abortus induces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8(+) T cell responses

artículo científico publicado en 2012

Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis

artículo científico publicado en 2010

Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages

article

Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2

artículo científico publicado en 2007

Brucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice

artículo científico publicado en 2014

Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus

artículo científico publicado en 2008

Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used

artículo científico publicado en 2003

Brucella outer membrane protein Omp31 is a haemin-binding protein

artículo científico publicado en 2006

Confronting the barriers to develop novel vaccines against brucellosis

artículo científico publicado en 2011

Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis

artículo científico publicado en 2002

Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice

artículo científico publicado en 2014

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection.

artículo científico publicado en 2009

Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection

artículo científico publicado en 2008

Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.

artículo científico publicado en 2004

Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.

artículo científico publicado en 2002

Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting

artículo científico publicado en 2007

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System

artículo científico publicado en 2019

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier

scholarly article by Lorena M Coria et al published 10 January 2019 in Journal of Controlled Release

Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy

artículo científico publicado en 2014

RomA, a Periplasmic Protein Involved in the Synthesis of the Lipopolysaccharide Tunes Down the Inflammatory Response Triggered by Brucella.

artículo científico publicado en 2018

Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.

artículo científico publicado en 2000

Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.

artículo científico publicado en 2012

The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Syste

article

The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams

artículo científico publicado en 2009

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

artículo científico publicado en 2003

The vaccine candidate BLSOmp31 protects mice against Brucella canis infection

artículo científico publicado en 2013

Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in mice

artículo científico publicado en 2013

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice

artículo científico publicado en 2017

Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins

artículo científico publicado en 2013

Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice

article by Maria Victoria Delpino et al published September 2007 in Vaccine

Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection

artículo científico publicado en 2005

Lista de obras de Juliana Cassataro

A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses

A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response

A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination

A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice

A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses

A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice

A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination

An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice

Antibodies to the CP24 protein of Brucella melitensis lack diagnostic usefulness in ovine brucellosis

Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae

Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge

Brucella abortus activates human neutrophils

Brucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases

Brucella abortus induces apoptosis of human T lymphocytes

Brucella abortus induces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8(+) T cell responses

Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis

Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages

Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2

Brucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice

Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus

Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used

Brucella outer membrane protein Omp31 is a haemin-binding protein

Confronting the barriers to develop novel vaccines against brucellosis

Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis

Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection.

Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection

Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.

Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.

Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier

Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy

RomA, a Periplasmic Protein Involved in the Synthesis of the Lipopolysaccharide Tunes Down the Inflammatory Response Triggered by Brucella.

Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.

Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.

The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Syste

The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

The vaccine candidate BLSOmp31 protects mice against Brucella canis infection

Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in mice

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice

Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins

Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice

Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection